Highlights
Population-specific genetic variants that alter responses to diabetes medication
A MWC programme of work around a SLC22A3 gene variant unique to Māori and Pacific peoples that could impact the way first line drug treatment is managed for people with type 2 diab
read the full story
A step towards precision medicine for Māori and Pacific Peoples
Research funded through the MWC Metabolic Health research theme programme has led to the understanding of how a gene variant unique to Māori and Pacific could impact the way first
read the full story
Unique genetic variant and mechanism drives powerful Type 2 diabetes protection
New light is shining on the role of genetics in the etiology and management of obesity and diabetes in New Zealand populations with MWC support through the Metabolic Disease Flagsh
read the full story
Dual approach drives precision medicine
Two pioneering studies by MWC investigators are looking at the resilience and risk factors for type 2 diabetes in Māori and Pacific peoples, both ultimately aimed at understanding
read the full story
Collaboration a bridge to new knowledge
Four years ago, MWC and The Moko Foundation formed the Waharoa ki te Toi Health Research Centre in Kaitaia to drive outreach including to deliver the Fructose in Schools (FIS) and
read the full story
MWC senior leadership team welcomes new appointees
We highlight the recent appointments of three exceptional scientists – Associate Professor Rinki Murphy, Professor Debbie Hay and Dr Nikki Moreland – to the Maurice Wilkins Centre
read the full story
Celebrations as regional research centres open
The MWC continued to strengthen its relationships with Māori communities in 2018. MWC Deputy Director Professor Peter Shepherd and Principal Investigator Professor Tony Merriman, i
read the full story
Mid-term review sets future direction
A comprehensive independent assessment found the Centre to be performing at a high level, producing distinct and positive benefits for New Zealand. It also enabled re-configuration
read the full story
‘Sugar in Schools’ study launched nationwide
The Maurice Wilkins Centre launched the ‘Sugar in Schools’ study in 2017 – a ground-breaking multi-year programme bringing science to thousands of schoolchildren across New Zealand
read the full story
Cells get increasing coverage
Human cells have always been important in Maurice Wilkins Centre research, but new developments open up new ground for both research and therapy.
read the full story
New insight into an established diabetes target
Facilitating the development of better medicines for diabetes, obesity and cardiovascular disease is a key driver behind some painstaking research at the Maurice Wilkins Centre to
read the full story
Genetic study challenges popular opinion
A new Maurice Wilkins Centre study is bringing together researchers from across the country to investigate the genetic factors that predispose some New Zealanders to a greater risk
read the full story
A fresh approach to diabetes (2013)
Type 2 diabetes is often caused by obesity, and weight-loss surgery usually reverses it. However, we don’t know precisely how this happens, and a new study at the MWC aims to find
read the full story
Dissecting drug side effects offers hope (2011)
Researchers from the Maurice Wilkins Centre have discovered how a common class of medicines causes diabetes-like symptoms, and their work suggests a promising way of managing these
read the full story
Clues to life-threatening organ failure (2010)
Relatively little is known about lymph but there is growing evidence that it can carry disease-causing toxins from the intestines throughout the body. Researchers associated with t
read the full story
Help with difficult diagnoses (2009)
Maurice Wilkins Centre technology is helping Auckland Hospital with difficult diagnoses.
read the full story